Program

In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries of innovation to design an event that works in today’s quickly changing environment. 

In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.

Practice of Use of Food Supplements in Cancer Patients

Speaker(s)

Töltösi E1, Boncz I2, Endrei D2, Kívés Z3
1Baxter Hungary Kft., Budapest, Hungary, 2University of Pécs, Pécs, Hungary, 3University of Pécs, PÉCS, BA, Hungary

Objectives: The use of complementary therapies is significant among cancer patients. The aim of the research was to find out what additional therapies are used by patients diagnosed with cancer. Besides, what kind of factors influence their choice between medicines and how much financial burden this means for them.

Methods: Quantitative cross-sectional research was performed among non-randomized patients (n=111) in Hungary. We applied a questionnaire survey, groups of questions: sociodemographic data, disease characteristics, dietary supplements used, information shared with physicians, source of information, costs, impact assessment. In addition to the descriptive statistical analysis χ2-test, Independent samples t-test, ANOVA were applied (p<0.05) with SPSS software.

Results: The mean age was 49.8 years. 33.4% use high doses of vitamins C and D, herbs that are considered effective. 48.6% inform the treating physician about the preparations used. Economically active people are significantly (p=0.006) less likely to use any additional treatment or consult a naturopath than inactive people. This may be related to the price of the preparations. Avemar is used by 68.5%, Aloe vera 56.8% and 52% use variations of cannabidiol (CBD). Among the reasons for use, the answer “I wanted to try everything that could help” was most often indicated by 74.2% (69 people). 25.2% spend 15.56 USD on different treatments and 27.9% spend more than 77.6 USD on alternative therapies. Those who spend between 15-30 USD per month are significantly (p=0.019) less satisfied (53.1%) with the outcome of treatment (satisfied with 20%). The most important sources of information are the physician (88.3%) and the Internet (55.9%).

Conclusions: Interviewed mostly started alternative therapies because they wanted to try everything that could help. Traditional treatments are thought to be too “mechanical” or frustrated with traditional treatments. Most of them spend more than 77 USD on alternative treatments in a month.

Code

PCR18

Topic

Patient-Centered Research

Topic Subcategory

Patient Behavior and Incentives, Patient Engagement

Disease

No Additional Disease & Conditions/Specialized Treatment Areas